Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Hoever

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Psychopharmacology (Oxford, England)|June 15, 2012
Orexin receptor antagonism: an ascending multiple-dose study with almorexantPetra Hoever, Sanne L de Haas, Georg Dorffner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2013
Elucidation of the metabolic pathways and the resulting multiple metabolites of almorexant, a dual orexin receptor antagonist, in humansJasper Dingemanse, Petra Hoever, Matthias Hoch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 2, 2014
Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramineHans G Cruz, Justin L Hay, Petra Hoever, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humansMatthias Hoch, Justin L Hay, Petra Hoever, et al.
Clinical Pharmacology in Drug Development|July 12, 2022
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's LymphomaAndres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, et al.
Blood Cancer Journal|December 6, 2019
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG studyMarinus van Oers, Lukas Smolej, Mario Petrini, et al.
Nature Medicine|January 30, 2007
Promotion of sleep by targeting the orexin system in rats, dogs and humansCatherine Brisbare-Roch, Jasper Dingemanse, Ralf Koberstein, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Psychopharmacology (Oxford, England)|June 15, 2012
Orexin receptor antagonism: an ascending multiple-dose study with almorexantPetra Hoever, Sanne L de Haas, Georg Dorffner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2013
Elucidation of the metabolic pathways and the resulting multiple metabolites of almorexant, a dual orexin receptor antagonist, in humansJasper Dingemanse, Petra Hoever, Matthias Hoch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 2, 2014
Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramineHans G Cruz, Justin L Hay, Petra Hoever, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2012
Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humansMatthias Hoch, Justin L Hay, Petra Hoever, et al.
Clinical Pharmacology in Drug Development|July 12, 2022
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's LymphomaAndres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, et al.
Blood Cancer Journal|December 6, 2019
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG studyMarinus van Oers, Lukas Smolej, Mario Petrini, et al.
Nature Medicine|January 30, 2007
Promotion of sleep by targeting the orexin system in rats, dogs and humansCatherine Brisbare-Roch, Jasper Dingemanse, Ralf Koberstein, et al.
Pageof 2